Viking Therapeutics Announces Proposed Offerings Of Common Stock And Convertible Senior Notes
VKTX•Proposed common stock and convertible senior notes offerings
Sept. 24 (Reuters) - Viking Therapeutics, Inc. (VKTX.O):
- Viking Therapeutics announces proposed offerings of common stock and convertible senior notes.
- Viking Therapeutics plans to offer $200 million of common stock and $200 million of convertible notes due 2032.
- Proceeds are expected to fund VK2735 and VK3019 clinical development and general corporate purposes.
